Introduction {#s1}
============

*Escherichia coli* (*E. coli*) O157:H7 is a significant foodborne pathogen that causes bloody diarrhea and occasionally, hemolytic-uremic syndrome (HUS) ([@r001]). These illnesses have been related to ground beef, fruit, vegetables, and undercooked food ([@r002]). On December 24, 2009, the United States Department of Agriculture Food Safety and Inspection Service (FSIS) issued a recall of 248,000 pounds of beef products from steak and poultry that have been contaminated with *E. coli* O157:H7 in Colorado, Iowa, Kansas, Michigan, South Dakota, and Washington ([@r007]).

Pathogenic *E. coli* caused 291 foodborne illness outbreaks from 2011 to 2012, accounting for 24.1% of total food poisoning outbreaks in Korea ([@r023]). According to the statistics from the Korea Centers for Disease Control and Prevention, foodborne outbreaks of pathogenic *E. coli* were frequently associated with the contamination of pickled vegetables, beef, pork, and drinking water in summer ([@r023]). In 2012, kimchi contaminated by *E. coli* O169 caused serious cases of enteritis in schoolchildren ([@r009]). Although enterotoxigenic *E. coli* is more prevalent than enterohemorrhagic *E. coli*, there is a significant risk for the contamination of *E. coli* O157:H7 in meat from livestock animals ([@r009]; Kang *et al*., 2004).

Bacteriophages are viruses causing lysis of the host bacteria. Since its discovery by Twort in 1915 and d'Herelle in 1917, bacteriophage has been exploited to control bacteria ([@r011]; Kutter and Sulakvelidze, 2004). With the emerging public health concern about antibiotic resistant bacteria, the use of bacteriophages to control pathogenic bacteria has received more attention by the food industry and medical science ([@r010]; [@r026]; [@r027]). The U.S. Food and Drug Administration (FDA) approved Listex P-100 (Micros Food Safety, Netherlands) and EcoShield (Intralytix, Inc., USA) for commercial use to clean hard surface in food processing plant and to reduce the risk of meat contamination by *Listeria monocytogenes* (*L. monocytogenes*) or *E. coli* O157:H7, respectively. In addition, previous studies showed the inhibitory effect of bacteriophage cocktails on *E. coli* O157:H7 on hard surfaces and in tomato, spinach, ground beef, and meat ([@r001]; [@r022]).

It was demonstrated that *E. coli* O157:H7 was reduced in cooked and raw beef by bacteriophage treatment ([@r015]; [@r016]). However, bacteriophages that target *E. coli* O157:H7 were not used in pork and chicken meat. Therefore, the aims of this study were to determine the optimal treatment of bacteriophage to control *E. coli* O157:H7 and to investigate the inhibition of *E. coli* O157:H7 inoculated on beef, pork, and chicken by bacteriophage.

Materials and Methods {#s2}
=====================

Preparation of bacteriophages and host {#s2a}
--------------------------------------

*E. coli* O157:H7 ATCC 43888, *E. coli* O157:H7 ATCC 43889, and *E. coli* O157:H7 ATCC 43890 were purchased from American Type Culture Collection (ATCC; USA). Host bacteria were grown in Luria Bertani (LB, Sigma-Aldrich, USA) broth on shaking incubator (SI-600R, Jeiotech, Korea) at 37℃ overnight.

Fourteen lytic bacteriophages against *E. coli* O157:H7 ATCC 43889 were obtained from the bacteriophage bank of Hankuk University of Foreign Studies in Korea ([Table 1](#t001){ref-type="table"}). The titration of each bacteriophage strain was determined by the plaque assay, as previously described ([@r015]; [@r016]). Briefly, 100 μL of *E. coli* O157:H7 and 100 μL of bacteriophage were diluted 10-fold with SM buffer (0.05 M Tris-HCl, 0.1 M NaCl, 0.008 M MgSO4, 0.01% gelatin, pH 7.5), mixed in a 1:1 ratio and incubated for 1 h in a shaking incubator (SI-600R, Jeiotech, Korea) at 150 rpm. Subsequently, the mixtures were inoculated in LBC soft agar (LB broth, 0.1% CaCl~2~, 0.6% agar). LBC soft agar was overlaid onto a substrate of LBC agar (LB agar, 0.1% CaCl~2~) and incubated at 37℃ for 18 h. Five milliliter of SM buffer were added to each plate exhibiting a sufficient number of bacteriophage plaques and plates were transferred to an orbital shaker (OS-752, Optima, Japan) at 100 rpm for 3 h. The supernatant was collected with a syringe (KOVAXSYRINGE 5 mL, Korea vaccine, Korea) with intermittent agitation and filtered through a 0.2 μm filter (minisart CA 16534, Sartorius Stedim Biotech A.G., Germany). For bacteriophage propagation, 500 μL of *E. coli* O157:H7 were inoculated into 100 mL LBC broth with 1.5 mL of 30% glucose (Sigma-Aldrich) and incubated at 37℃ for 1 h. Subsequently, bacteriophages were inoculated into the E. coli/LBC broth mixture, incubated at 37℃ for 5 h and the cultured broth filtered through a 0.2-μm syringe filter. The final titer of bacteriophages was adjusted to 10^9^-10^11^ plaque forming unit (PFU)/mL and bacteriophages stored at 4℃ until further use.

###### Lytic bacteriophage isolates against *E. coli* O157:H7 used in this study

  Bacteriophage strain   Origin of isolation   Host strain                   Size of Plague (mm)
  ---------------------- --------------------- ----------------------------- ---------------------
  ECO3                   Sewage                *E. coli* O157:H7 ATCC43889   1-2
  ECO4                   Sewage                *E. coli* O157:H7 ATCC43889   1
  BPECO5                 Sewage                *E. coli* O157:H7 ATCC43889   1-2
  BPECO6                 Sewage                *E. coli* O157:H7 ATCC43889   1
  BPECO7                 Sewage                *E. coli* O157:H7 ATCC43889   \<1
  BPECO9                 Sewage                *E. coli* O157:H7 ATCC43889   \<1
  BPECO15                Sewage                *E. coli* O157:H7 ATCC43889   \<1
  BPECO17                Sewage                *E. coli* O157:H7 ATCC43889   \<1
  BPECO18                Sewage                *E. coli* O157:H7 ATCC43889   1-2
  BPECO19                Sewage                *E. coli* O157:H7 ATCC43889   6-8
  BPECO20                Sewage                *E. coli* O157:H7 ATCC43889   1
  BPECO22                Sewage                *E. coli* O157:H7 ATCC43889   \<1
  BPECO24                Sewage                *E. coli* O157:H7 ATCC43889   6-7
  BPECO25                Sewage                *E. coli* O157:H7 ATCC43889   1-2

*In vitro* activity of bacteriophage against *E. coli* O157:H7 {#s2b}
--------------------------------------------------------------

For comparing the lytic activity of each bacteriophage strains, *E. coli* O157:H7 was treated with 10,000 multiplicity of infection (MOI) used in previous studies ([@r015]; [@r016]). Bacteriophage activity was measured by challenge test, as described, with slight modifications ([@r022]). Briefly, *E. coli* O157:H7 was cultured in LB broth at 37℃ overnight and diluted to 1×10^5^ colony-forming unit (CFU)/mL with 0.1% peptone water. The titer of each bacteriophage strain was adjusted to 1×10^9^ PFU/mL with SM buffer. Each bacteriophage strain was mixed with *E. coli* O157:H7 and transferred to a shaking incubator at 37℃. After 10, 20, 40, and 60 min incubation, 10-fold diluted samples were plated on SMAC and incubated at 37℃ overnight and the populations of *E. coli* O157:H7 were counted.

Based on the comparison of lytic activity between bacteriophage strains, BPECO19 showed the strongest lytic activity against *E. coli* O157:H7 in this study. To examine the MOI-dependent inhibition of BPECO19, 1×10^5^ CFU/mL of *E. coli* O157:H7 was treated *in vitro* with 10, 100, 1,000, and 10,000 MOI of bacteriophage BPECO19 at 37℃ for 0, 10, 20, 40, and 60 min. Subsequently, each sample was 10-fold diluted and plated. After overnight incubation at 37℃, the population of host bacteria was counted.

Control of *E. coli* O157:H7 on meat samples by bacteriophage BPECO19 {#s2c}
---------------------------------------------------------------------

Beef, pork, and chicken meat were purchased at a local market (Korea). Each meat sample was aseptically cut to squares of 2 × 2 cm. Experimental design and treatment time were modified from previous studies ([@r001]; [@r004]; [@r015]; [@r016]). Cocktail of *E. coli* O157:H7 ATCC 43888, *E. coli* O157:H7 ATCC 43889, and *E. coli* O157: H7 ATCC 43890 at a concentration of 1×10^5^ CFU/cm^2^ were inoculated on the surface of each meat sample with pipet spreading. Subsequently, each meat sample was inoculated with 1,000, 10,000 and 100,000 MOI bacteriophage BPECO 19 and stored at 4℃ and 37℃ for 1, 2, 4, 8, 12, 24, 48, 72, 120, and 168 h post-inoculation. Positive control was contaminated with *E. coli* O157:H7 in meat without bacteriophage treatment. Negative control was not contaminated with *E. coli* O157:H7 in meat treated with same amount of LB media instead of bacteriophage.

Statistical analysis {#s2d}
--------------------

Each experimental group had 3 technical replicates. Three times experiments were performed independently. Data from each group were expressed as mean and standard deviation. Statistical significance was analyzed at *p*\<0.05 by one-way analysis of variance (ANOVA) and paired *t*-test using Statistical Package for Social Science (SPSS) software v18 (IBM, USA).

Results {#s3}
=======

Selection of bacteriophage strain {#s3a}
---------------------------------

The origin and plague size of 14 bacteriophage strains were shown in [Table 1](#t001){ref-type="table"}. While 12 bacteriophages showed the pin-pointed plague with less than 1-2 mm diameter, 6-8 mm plague of BPECO19 and BPECO 24 was prominently observed ([Table 1](#t001){ref-type="table"}). When the lytic activity of 14 bacteriophage strains was assessed at 10,000 MOI against *E. coli* O157:H7 cultured *in vitro*, 10 bacteriophage strains caused less than 1-2 log reduction/ml at 1 h (data not shown). Among them, bacteriophage ECO3, BPECO6, BPECO18, and BPECO19 significantly reduced *E. coli* O157:H7 within 1 h ([Fig. 1](#f001){ref-type="fig"}). Especially, bacteriophage BPECO19 decreased *E. coli* O157:H7 by 4.53 log in 10 min (*p*\<0.05) and *E. coli* O157:H7 was not detected in 20 min treatment (*p*\<0.001) ([Fig. 1](#f001){ref-type="fig"}). Whereas bacteriophage ECO3 and BPECO18 gradually decreased host bacteria until 60 min (*p*\<0.05) ([Fig. 1](#f001){ref-type="fig"}), bacteriophage BPECO6 reduced *E. coli* O157:H7 by 2.18 log at 40 min (*p*\<0.05) but the effect was less pronounced after 60 min ([Fig. 1](#f001){ref-type="fig"}). When the plague size and lytic effect of each bacteriophage strain was considered, bacteriophage BPECO19 was selected to control *E. coli* O157:H7 in artificially contaminated meat samples.

![***In vitro* challenge of individual bacteriophages against *E. coli* O157:H7 ATCC 43889 in liquid culture at 37℃ for 1 h at a multiplicity of infection (MOI) of 10000.** (■) Control, ( ● ) Bacteriophage ECO 3, ( ○ ) Bacteriophage BPECO 6, (▼ ) Bacteriophage BPECO 18, and (△) Bacteriophage BPECO 19.](kosfa-36-186-f001){#f001}

Inhibition of *E. coli* O157:H7 *in vitro* {#s3b}
------------------------------------------

When *E. coli* O157:H7 was treated *in vitro* with 10, 100, 1,000, and 10,000 MOI of BPECO19 up to 1 h, MOI-dependent reduction of *E. coli* was clearly shown in [Fig. 2](#f002){ref-type="fig"}. BPECO19 at 10,000 MOI completely inhibited *E. coli* O157:H7 in 10 min (*p*\<0.05). BPECO19 at 1,000 MOI gradually reduced *E. coli* O157:H7 from 5.10 Log CFU/mL to 0.99 Log CFU/mL in 60 min (*p*\<0.05). BPECO19 at 100 MOI decreased *E. coli* O157:H7 by 0.36 log in 60 min (*p*\<0.05). Although 10 MOI transiently decreased *E. coli* O157:H7 by 0.29 log in 20 min, host bacteria was not significantly reduced in 60 min ([Fig. 2](#f002){ref-type="fig"}). From this data, treatment condition of bacteriophage BPECO19 to control *E. coli* O157:H7 in meat sample was determined.

![**Inhibition of *E. coli* O157:H7 ATCC 43889 in liquid culture at 37℃ for 1 h depending on multiplicity of infection (MOI) of BPECO 19.** (●) Control, (○) treatment with bacteriophage BPECO 19 at 10 MOI, ( ▼ ) treatment with bacteriophage BPECO 19 at 100 MOI, ( △) treatment with bacteriophage BPECO 19 at 1,000 MOI, and ( ■ ) treatment with bacteriophage BPECO 19 at 10,000 MOI.](kosfa-36-186-f002){#f002}

Inhibition of *E. coli* O157:H7 in beef {#s3c}
---------------------------------------

When bacteriophage BPECO19 was applied to artificially contaminated beef at 4℃, *E. coli* O157:H7 reduced at 1,000, 10,000, 100,000 MOI proportionately. However, BPECO19 could not inhibit *E. coli* O157:H7 in beef stored at 37℃ (data not shown). *E. coli* O157:H7 was gradually reduced from 5.09 Log CFU/cm^2^ to 1.37 Log CFU/cm^2^ at 4 h (*p*\<0.001) and was inhibited completely (*p*\<0.001) after 8 h by 100,000 MOI of bacteriophage BPECO19. At 10,000 and 1,000 MOI, initial contamination level of *E. coli* O157:H7 reduced to 3.10 Log CFU/cm^2^ (*p*\<0.001) in 48 h and 4.56 Log CFU/cm^2^ (*p*\<0.01) in 8 h, respectively ([Fig. 3](#f003){ref-type="fig"}). After those time points, populations of *E. coli* O157:H7 slightly increased or maintained. However, it was clear that *E. coli* O157:H7 was significantly reduced by treatment of bacteriophage BPECO19 in beef.

![**Effect of bacteriophage BPECO 19 against *E. coli* O157: H7 ATCC 43889 on the surface of raw beef incubated at 4℃ for 168 h at a multiplicity of infection (MOI) of 1,000, 10,000 and 100,000.** (●) negative control, (○) positive control, ( ▼ ) treatment with bacteriophage BPECO 19 at 1,000 MOI, (△) treatment with bacteriophage BPECO 19 at 10,000 MOI, and ( ■ ) treatment with bacteriophage BPECO 19 at 100,000 MOI.](kosfa-36-186-f003){#f003}

Inhibition of *E. coli* O157:H7 in pork {#s3d}
---------------------------------------

In comparison of storage temperature at 4℃ and 37℃, treatment of BPECO19 significantly reduced *E. coli* O157: H7 in pork at 4℃. Whereas 100,000 MOI of bacteriophage BPECO19 completely inhibited *E. coli* O157:H7 in beef in 8 h (*p*\<0.001), *E. coli* O157:H7 spiked in pork was completely inhibited not only by 100,000 MOI (*p*\<0.001) in 8 h but also by 10,000 MOI in 72 h (*p*\<0.001) ([Fig. 4](#f004){ref-type="fig"}). A significant 0.53 log (*p*\<0.001) reduction of *E. coli* O157:H7 by 1,000 MOI of bacteriophage was observed after 8 h ([Fig. 4](#f004){ref-type="fig"}). These findings demonstrate that inhibition of *E. coli* O157:H7 by bacteriophage BPECO 19 was more effective in pork than in beef ([Fig. 4](#f004){ref-type="fig"}).

![**Effect of bacteriophage BPECO 19 against *E. coli* O157: H7 ATCC 43889 on the surface of raw pork incubated at 4℃ for 168 h at a multiplicity of infection (MOI) of 1,000, 10,000 and 100,000.** (●) negative control, (○) positive control, ( ▼ ) treatment with bacteriophage BPECO 19 at MOI 1,000, (△) treatment with bacteriophage BPECO 19 at MOI 10,000, and ( ■ ) treatment with bacteriophage BPECO 19 at 100,000 MOI.](kosfa-36-186-f004){#f004}

Inhibition of *E. coli* O157:H7 in chicken meat {#s3e}
-----------------------------------------------

Although BPECO19 could not control *E. coli* O157:H7 in chicken stored at 37℃ (data not shown), it significantly reduced *E. coli* O157:H7 in chicken under the refrigeration condition. Whereas a transient increase in *E. coli* O 157:H7 bacterial load after bacteriophage BPECO19 treatment was observed in beef and pork, suppression of *E. coli* O157:H7 was constant in chicken meat ([Fig. 5](#f005){ref-type="fig"}). A rapid 4.65 log reduction of *E. coli* O157:H7 by 100,000 MOI was reported after 1 h (*p*\<0.001), a 4.90 log (*p*\<0.001) reduction observed after 2 h and host bacteria was absent after 4 h (*p*\<0.001) ([Fig. 5](#f005){ref-type="fig"}). Whereas *E. coli* O157: H7 was not reduced completely by lower number of MOI, after 168 h, 1,000 and 10,000 MOI of bacteriophage BPECO19 significantly reduced *E. coli* O157:H7 by 3.02 log (*p*\<0.001) and 4.39 log (*p*\<0.001), demonstrating inhibition of *E. coli* O157:H7 in chicken meat.

![**Effect of bacteriophage BPECO 19 against *E. coli* O157: H7 ATCC 43889 on the surface of raw chicken meat incubated at 4℃ for 168 h at a multiplicity of infection (MOI) of 1,000, 10,000 and 100,000.** (● ) negative control, (○) positive control, (▼) treatment with bacteriophage BPECO 19 at 1,000 MOI, ( △) treatment with bacteriophage BPECO 19 at 10,000 MOI, and ( ■ ) treatment with bacteriophage BPECO 19 at 100,000 MOI.](kosfa-36-186-f005){#f005}

Discussion {#s4}
==========

In this study, bacteriophage BPECO19 with prominent plague and lytic activity under *in vitro* conditions was the most promising strain against *E. coli* O157:H7 although all bacteriophage strains inhibited *E. coli* O157:H7 with various degrees. When bacteriophage BPECO19 was applied to control *E. coli* O157:H7 in artificially contaminated meat samples, it significantly reduced *E. coli* O157:H7 in beef, pork, and chicken stored at 4℃ which is used to keep fresh meats. Similarly, bacteriophage A511 and P100 significantly reduced *L. monocytogenes* in seafood, cheese, brine, chocolate milk, and vegetables under refrigerated conditions ([@r003]; [@r024]). Because the growth of mesophilic bacteria is decreased or halt under refrigeration temperature ([@r008]), the resumption of *E. coli* O157:H7 did not exceed the lytic activity of bacteriophage BPECO19 in meat at 4℃. Combined with the lytic activity of bacteriophage BPECO19, cold temperature may contribute to effectively reduce *E. coli* O157:H7 in meat.

Compared with different temperatures, previous studies interestingly reduced pathogen at high temperature more than at low temperature or under refrigeration condition ([@r016]; [@r022]; [@r028], [@r029]). Their data was explained by the principle that diffusion or absorption rate of bacteriophage was proportionate to temperature. As bacteriophage adsorption was determined by second-order kinetics, *−dp/dt=κPB* (*κ*: phage absorption rate, *P*: phage concentration, *B*: bacterial concentration), high temperature seemed to increase the lytic activity of bacteriophage mixture BEC8 ([@r024]; [@r028], [@r029]). On the contrary, the other study demonstrated that phage FAHEc1 was not effective to control *E. coli* O157:H7 in meat at 37℃ but in broth at 4℃ because the bacterial resumption at high temperature exceeded the lytic activity of bacteriophage ([@r015]). Previous study was consistent with this finding that BPECO19 could not control *E. coli* O157:H7 in meat stored at 37℃ ([@r015]). Therefore, storage at high temperature is not recommended to fresh meats because of the risk of outgrowth of spoilage bacteria or pathogens although some phages used in previous studies could be effective to control certain pathogens.

In accordance of food matrix or type of surface, MOI or concentration of bacteriophages varied in previous applications ([@r001]; [@r004]; [@r028], [@r029]; [@r030]). While 100 MOI of bacteriophage cocktail was effective to control pathogens on hard surfaces or leafy green vegetables, an MOI higher than 10,000 or 10^7^ PFU/mL of bacteriophages was used in previous studies to control *E. coli* O157: H7 on cooked or raw beef ([@r015]; [@r028], [@r029]). It was reported that 20,000 MOI of bacteriophage FAHEc1 decreased 1.4×10^4^ CFU *E. coli* O157:H7 to undetectable level on beef in 1 h and lower MOI of FAHEc1 was not effective ([@r015]). In other study to extend the shelf life of rib-eye steaks, 10,000 MOI of *Pseudomonas* bacteriophage could limit meat discoloration without sensory change, whereas low MOI could not ([@r013]). Like previous studies, lytic activity of bacteriophages BPECO19 significantly increased with MOI ([@r004]; [@r015]; [@r016]; [@r020]; [@r022]; [@r025]; [@r028], [@r029]; [@r030]). For the application of bacteriophage on meat, the higher than 10,000 MOI treatment of BPECO19 were needed to control *E. coli* O157:H7. As it is critical for food applications and medical treatments to determine the optimal MOI of bacteriophages, the preparation of high titer stocks in large volumes is required for bacteriophage applications in agriculture, animal husbandry, and food science ([@r014]8; [@r030]). Since BPECO19 generally reached a titer of 10^11^ PFU/ml after 5 h of propagation at 37℃ (data not shown), this strain could be very useful for applications that require high titer bacteriophage.

Compared with meat samples, inhibition of *E. coli* O157: H7 by BPECO19 was prominent in beef and pork rather than chicken in this study. Several factors were suggested to inhibit the lytic activity of bacteriophage in meat and milk ([@r022]; [@r024]). Among them, the high moisture content of the meats reduced the lytic activity by reducing the diffusion of bacteriophages to the host bacteria ([@r024]). As phage diffusion was determined by phage intrinsic properties and food matrix ([@r011]9), the moisture and properties of each meat samples might contribute to the difference in diffusion rate and lytic activity of bacteriophage. Similarly, the binding to heat-labile immunoglobulin proportionally reduced the lytic activity of phage K against *Staphylococcus aureus* (*S. aureus*). In addition, whey protein inhibited binding of phage K to *S. aureus* ([@r012]). In meat samples, abundance of immunoglobulins may affect the activity of bacteriophage BPECO19 and presence of additional inhibitory factors may explain the high titer required to inactivate host pathogen in meat samples.

The emergence of phage-resistant bacteria was a critical issue to be solved for the application of bacteriophages in food industry. Thus, a cocktail of broad-host-range phages was recommended in bacteriophage applications in order to prevent or reduce the chance of development of bacteriophage-resistant bacteria ([@r024]). Three *E. coli* O157:H7 lytic bacteriophage cocktail ECP-100 is commercially called as EcoShield and was used to control *E. coli* O157:H7 in tomatoes, spinach, broccoli, lettuce, steak, and ground beef ([@r001]; [@r006]). The bacteriophage cocktail BEC8 also significantly reduced *E. coli* on steel and ceramic chips surfaces ([@r028], [@r029]).

However, several controversial studies reported that the use of bacteriophage cocktail could be associated with the emergence of bacteriophage-resistant bacteria ([@r001]; [@r004]; [@r030]). As the adsorption of bacteriophage to the cell wall of the host bacteria requires a specific receptor, competition for binding to the shared receptor by bacteriophages in cocktails could cause mutations of receptor against *E. coli* O157:H7 ([@r001]; [@r021]). Accordingly, the treatment with single bacteriophages such as *Listeria monocytogenes* or bacteriophage P- 100 was not associated with appearance of bacteriophage--resistant bacteria ([@r005]; [@r029]; [@r030]). Therefore, it is of interest that bacteriophage BPECO19 alone successfully controlled *E. coli* O157:H7 in three types of meat samples. Considering that the emergence of bacteriophage-resistant or antibiotic-resistant bacteria might become a significant problem, the effect of single or cocktail treatment of bacteriophages on host mutation should be invested in further study.

To summarize, bacteriophage BPECO19 strain was selected for the biocontrol of *E. coli* O157:H7 under *in vitro* condition and on beef, pork, and chicken meat. In addition, bacteriophage BPECO19 alone reduced *E. coli* O157: H7 in a MOI-dependent manner under refrigerated condition. Although this study used the simple spreading method of bacteriophage at 100,000 MOI, the spraying method and combination with antimicrobials were attempted to enhance the biocontrol efficiency ([@r020]; [@r025]). As an antimicrobial aerosol was successfully used to control foodborne pathogens in pork ([@r019]), aerosolization technique of bacteriophages could be applied to enhance meat safety in the further study.
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